D. E. Shaw & Co., Inc. Aytu Biopharma, Inc Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.46 - $1.08 $17,523 - $41,141	-38,094 Reduced 67.63%	18,235 $13,000
Q1 2022 May 16, 2022	SELL	$1.08 - $1.55 $57,573 - $82,628	-53,309 Reduced 48.62%	56,329 $61,000
Q4 2021 Feb 14, 2022	SELL	$1.35 - $2.95 $113,023 - $246,976	-83,721 Reduced 43.3%	109,638 $148,000
Q3 2021 Nov 15, 2021	BUY	$2.78 - $5.12 $270,885 - $498,897	97,441 Added 101.59%	193,359 $557,000
Q2 2021 Aug 16, 2021	BUY	$4.73 - $7.56 $453,692 - $725,140	95,918 New	95,918 $480,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $102M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.